Gevo (GEVO) Shares Advance Heading into Market Close
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Gevo (NASDAQ: GEVO) shares advanced heading into the close of trading on Monday, and were up nearly 15% for the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gevo (GEVO) Says EPA Approves Pathway for Isobutanol as an Advanced Biofuel
- Procter & Gamble (PG) January volatility elevated at 49 into shares rally 2.6% in premarket
- Puts with increasing volatility movement and volume: WBA RAD TDG
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!